Find an actor
Journée de l'Innovation 2017 aux HUG Jeudi 19 octobre19.10.201711ème Journée de l’innovation au Centre de l’innovation des HUG. Conférences, concours de pitchs, remise des...
Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding roundPryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital...
DFB Pharmaceuticals Inc.Medical Devices, Consumables & ReagentsSummary of activity
DFB BioScience's primary focus is in the field of Cell Biology and Cell based therapies. The company develops Cell based therapies for treating chronic and acute wounds. Our R&D program includes several products at different development stage (preclinical, clinical, market approval). DFB BioScience can also provide manufacturing services for cell banking and Cell based products clinical manufacturing.
DFB BioScience is one of DFB Pharmaceuticals’ International branches. DFB Pharmaceuticals Inc., the mother company, is a fully integrated pharmaceutical group composed of two main divisions, DPT Laboratories, a Contract Manufacturing Organization providing customers with drug development and manufacturing services, and Healthpoint, which develops & markets pharmaceutical and medical products for chronic wounds.